Equillium
30 hedge funds and large institutions have $37.1M invested in Equillium in 2018 Q4 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
26.16% more ownership
Funds ownership: 0% → 26.16% (+26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$18.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$17.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.9M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$3.82M |
| 5 |
BlackRock
New York
|
+$2.99M |
Top Sellers
EQ Hedge Fund Activity: Q4 2018 in Review
30 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Equillium (EQ) for Q4 2018, worth a combined $37.1M.
Buyers outnumbered sellers: 30 funds opened new EQ positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $18.8M.
- 30 institutional investors held Equillium (EQ) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $37.1M of Equillium stock for Q4 2018.
- 30 funds opened new Equillium positions in Q4 2018 and 0 closed out, a net change of +30 holders.
- The largest Equillium buyer in Q4 2018 was PFM Health Sciences, an estimated $18.8M added.
Based on aggregated 13F filings for Q4 2018.